DNA encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and a recombinant cell line expressing a functional human alpha7 subunit of neuronal nicotinic acetylcholine receptor
Abstract
Isolated nucleic acid molecules, i.e., DNA or RNA encoding human neuronal nicotinic acetylcholine receptor α and β subunits, mammalian and amphibian cells containing said DNA, methods for producing α and β subunits and recombinant (i.e., isolated or substantially pure) α subunits and β subunits are provided. In addition, cells expressing various multimeric combinations of subunits (i.e., α 1 , α 2 α 3 α 4 α 5 α 6 and/or α 7 in combination with at least one of an α and β subunit are also provided. A recombinant, non-human cell line expressing the human α 7 subunit of nAChR is also disclosed.
Claims
exact text as granted — not AI-modified1 - 13 . (canceled)
14 . A stably transfected rodent cell line which has been engineered to express a heterologous protein, said cell line comprising a host cell transformed or transfected with a heterologous nucleic acid molecule comprising a sequence of nucleotides or ribonucleotides that inducibly express an α 7 subunit of a human neuronal nicotinic acetylcholine receptor, wherein said α 7 subunit comprises a sequence of nucleotides selected from the group consisting of:
(a) a sequence of nucleotides as ser forth in SEQ ID No: 11 which encode a human α 7 subunit. (b) a sequence of nucleotides that encode a polypeptide as set forth in SEQ ID No: 12; (c) a sequence of nucleotides degenerate with the human α 7 subunit polypeptide encoding sequence of (a) or (b).
15 . The stable transfected cell line according to claim 14 , wherein the cell line is derived from rat pituitary tumor tissue.
16 . The stably transfected cell line as claimed in claim 14 wherein the rodent cell line is a mouse GH 4 C 1 cell line.
17 . The cell line according to claim 14 wherein the heterologous protein is a functional human neuronal nicotinic acetylcholine receptor.
18 . The cell line according to claim 14 , further comprising a marker gene, wherein expression of the marker gene indicates expression of the heterologous protein.
19 . The cell line according to claim 14 , wherein the heterologous nucleic acid molecule is contained within an expression vector.
20 . The stable transfected cell line according to claim 14 , wherein the polypeptide of SEQ ID NO: 12 is the only heterologous acetylcholine receptor subunit expressed by the cell.
21 . A recombinant host cell comprising a heterologous nicotinic acetylcholine receptor that comprises a subunit encoded by a heterologous nucleic acid molecule comprising a sequence of nucleotides or ribonucleotides as set forth in SEQ ID No: 11.
22 . A recombinant host cell comprising a heterologous nicotinic acetylcholine receptor that comprises a subunit encoded by a heterologous nucleic acid molecule wherein said nucleic acid molecule encodes a polypeptide comprising the sequence of amino acids as set forth in SEQ ID No: 12.
23 . The host cell according to claim 22 , wherein the polypeptide of SEQ ID NO: 12 is the only heterologous acetylcholine receptor subunit expressed by the cell.Join the waitlist — get patent alerts
Track US2005287663A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.